Ignite Creation Date:
2024-05-06 @ 11:16 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03473691
Status:
WITHDRAWN
Last Update Posted:
2018-06-01
First Post:
2018-02-14
Brief Title:
Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer
Sponsor:
University of Virginia
Organization:
University of Virginia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2018-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-14
First Submit QC Date:
March 14 2018
Study First Post Date:
2018-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-30
Last Update Post Date:
2018-06-01
Last Update Post Date Type:
ACTUAL